Skip to search.
 TSX Up0.84% TSX Ventures 0.00%

Alnylam Pharmaceuticals, Inc. (ALNY)

-NasdaqGS

27.44 Up 0.23(0.85%) May 17, 4:00PM EDT|After Hours : 27.44 0.00 (0.00%) May 17, 4:32PM EDT

Add to Portfolio
Analyst EstimatesGet Analyst Estimates for:
Earnings EstCurrent Qtr.
Jun 2013		Next Qtr.
Sep 2013		Current Year
Dec 2013		Next Year
Dec 2014
Avg. Estimate-0.34-0.37-1.33-1.81
No. of Analysts7.007.008.008.00
Low Estimate-0.39-0.50-1.61-2.17
High Estimate-0.29-0.31-1.07-1.57
Year Ago EPS-0.25-0.38-1.37-1.33
Revenue EstCurrent Qtr.
Jun 2013		Next Qtr.
Sep 2013		Current Year
Dec 2013		Next Year
Dec 2014
Avg. Estimate9.32M9.22M45.41M35.91M
No. of Analysts7778
Low Estimate7.63M7.63M40.00M27.80M
High Estimate11.57M11.57M53.37M46.00M
Year Ago Sales20.88M16.76M66.72M45.41M
Sales Growth (year/est)-55.40%-45.00%-31.90%-20.90%
Earnings HistoryJun 2012Sep 2012Dec 2012Mar 2013
EPS Est-0.19-0.31-1.43-0.29
EPS Actual-0.25-0.38-0.46-0.15
Difference-0.06-0.070.970.14
Surprise %-31.60%-22.60%67.80%48.30%
EPS TrendsCurrent Qtr.
Jun 2013		Next Qtr.
Sep 2013		Current Year
Dec 2013		Next Year
Dec 2014
Current Estimate-0.34-0.37-1.33-1.81
7 Days Ago-0.34-0.37-1.33-1.81
30 Days Ago-0.37-0.42-1.53-1.86
60 Days Ago-0.37-0.42-1.53-1.86
90 Days Ago-0.35-0.42-1.64-1.88
EPS RevisionsCurrent Qtr.
Jun 2013		Next Qtr.
Sep 2013		Current Year
Dec 2013		Next Year
Dec 2014
Up Last 7 Days0000
Up Last 30 Days5675
Down Last 30 Days0000
Down Last 90 DaysN/AN/AN/AN/A
Growth EstALNYIndustrySectorS&P 500
Current Qtr.-36.00%N/AN/A11.80%
Next Qtr.2.60%N/AN/A16.60%
This Year2.90%N/A9.70%9.10%
Next Year-36.10%N/A13.20%12.60%
Past 5 Years (per annum)0.00%N/AN/AN/A
Next 5 Years (per annum)-6.60%13.14%13.69%9.37%
Price/Earnings (avg. for comparison categories)-20.46-0.683.2113.29
PEG Ratio (avg. for comparison categories)3.10-5.56-0.681.32
Currency in USD.